BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

596 related articles for article (PubMed ID: 25594584)

  • 21. Characterization of a splice-site mutation in the tumor suppressor gene FLCN associated with renal cancer.
    Bartram MP; Mishra T; Reintjes N; Fabretti F; Gharbi H; Adam AC; Göbel H; Franke M; Schermer B; Haneder S; Benzing T; Beck BB; Müller RU
    BMC Med Genet; 2017 May; 18(1):53. PubMed ID: 28499369
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Sporadic hybrid oncocytic/chromophobe tumor of the kidney: a clinicopathologic, histomorphologic, immunohistochemical, ultrastructural, and molecular cytogenetic study of 14 cases.
    Petersson F; Gatalica Z; Grossmann P; Perez Montiel MD; Alvarado Cabrero I; Bulimbasic S; Swatek A; Straka L; Tichy T; Hora M; Kuroda N; Legendre B; Michal M; Hes O
    Virchows Arch; 2010 Apr; 456(4):355-65. PubMed ID: 20300772
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Novel intronic germline FLCN gene mutation in a patient with multiple ipsilateral renal neoplasms.
    Gatalica Z; Lilleberg SL; Vranic S; Eyzaguirre E; Orihuela E; Velagaleti G
    Hum Pathol; 2009 Dec; 40(12):1813-9. PubMed ID: 19733897
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Novel germline mutations in FLCN gene identified in two Chinese patients with Birt-Hogg-Dubé syndrome.
    Li T; Ning X; He Q; Gong K
    Chin J Cancer; 2017 Jan; 36(1):4. PubMed ID: 28069055
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Splice-site mutation causing partial retention of intron in the FLCN gene in Birt-Hogg-Dubé syndrome: a case report.
    Furuya M; Kobayashi H; Baba M; Ito T; Tanaka R; Nakatani Y
    BMC Med Genomics; 2018 May; 11(1):42. PubMed ID: 29720200
    [TBL] [Abstract][Full Text] [Related]  

  • 26. FLCN gene-mutated renal cell neoplasms: mother and daughter cases with a novel germline mutation.
    Nagashima Y; Furuya M; Gotohda H; Takagi S; Hes O; Michal M; Grossmann P; Tanaka R; Nakatani Y; Kuroda N
    Int J Urol; 2012 May; 19(5):468-70. PubMed ID: 22211584
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Case Report of Birt-Hogg-Dubé Syndrome: Germline Mutations of FLCN Detected in Patients With Renal Cancer and Thyroid Cancer.
    Dong L; Gao M; Hao WJ; Zheng XQ; Li YG; Li XL; Yu Y
    Medicine (Baltimore); 2016 May; 95(22):e3695. PubMed ID: 27258496
    [TBL] [Abstract][Full Text] [Related]  

  • 28. PRDM10 RCC: A Birt-Hogg-Dubé-like Syndrome Associated With Lipoma and Highly Penetrant, Aggressive Renal Tumors Morphologically Resembling Type 2 Papillary Renal Cell Carcinoma.
    Schmidt LS; Vocke CD; Ricketts CJ; Blake Z; Choo KK; Nielsen D; Gautam R; Crooks DR; Reynolds KL; Krolus JL; Bashyal M; Karim B; Cowen EW; Malayeri AA; Merino MJ; Srinivasan R; Ball MW; Zbar B; Marston Linehan W
    Urology; 2023 Sep; 179():58-70. PubMed ID: 37331486
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Familial multiple discoid fibromas: a look-alike of Birt-Hogg-Dubé syndrome not linked to the FLCN locus.
    Starink TM; Houweling AC; van Doorn MB; Leter EM; Jaspars EH; van Moorselaar RJ; Postmus PE; Johannesma PC; van Waesberghe JH; Ploeger MH; Kramer MT; Gille JJ; Waisfisz Q; Menko FH
    J Am Acad Dermatol; 2012 Feb; 66(2):259.e1-9. PubMed ID: 21794948
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Therapeutic targeting the loss of the birt-hogg-dube suppressor gene.
    Lu X; Wei W; Fenton J; Nahorski MS; Rabai E; Reiman A; Seabra L; Nagy Z; Latif F; Maher ER
    Mol Cancer Ther; 2011 Jan; 10(1):80-9. PubMed ID: 21220493
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Renal cell tumour characteristics in patients with the Birt-Hogg-Dubé cancer susceptibility syndrome: a retrospective, multicentre study.
    Benusiglio PR; Giraud S; Deveaux S; Méjean A; Correas JM; Joly D; Timsit MO; Ferlicot S; Verkarre V; Abadie C; Chauveau D; Leroux D; Avril MF; Cordier JF; Richard S;
    Orphanet J Rare Dis; 2014 Oct; 9():163. PubMed ID: 25519458
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Pathology of Birt-Hogg-Dubé syndrome: A special reference of pulmonary manifestations in a Japanese population with a comprehensive analysis and review.
    Furuya M; Nakatani Y
    Pathol Int; 2019 Jan; 69(1):1-12. PubMed ID: 30632664
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Benign clear cell "sugar" tumor of the lung in a patient with Birt-Hogg-Dubé syndrome: a case report.
    Gunji-Niitsu Y; Kumasaka T; Kitamura S; Hoshika Y; Hayashi T; Tokuda H; Morita R; Kobayashi E; Mitani K; Kikkawa M; Takahashi K; Seyama K
    BMC Med Genet; 2016 Nov; 17(1):85. PubMed ID: 27871249
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Folliculin deficient renal cancer cells show higher radiosensitivity through autophagic cell death.
    Zhang Q; Si S; Schoen S; Jin XB; Chen J; Wu G
    J Urol; 2014 Jun; 191(6):1880-8. PubMed ID: 24434776
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Birt Hogg-Dubé syndrome-associated FLCN mutations disrupt protein stability.
    Nahorski MS; Reiman A; Lim DH; Nookala RK; Seabra L; Lu X; Fenton J; Boora U; Nordenskjöld M; Latif F; Hurst LD; Maher ER
    Hum Mutat; 2011 Aug; 32(8):921-9. PubMed ID: 21538689
    [TBL] [Abstract][Full Text] [Related]  

  • 36. FLCN-Driven Functional Adrenal Cortical Carcinoma with High Mitotic Tumor Grade: Extending the Endocrine Manifestations of Birt-Hogg-Dubé Syndrome.
    Hofstedter R; Sanabria-Salas MC; Di Jiang M; Ezzat S; Mete O; Kim RH
    Endocr Pathol; 2023 Jun; 34(2):257-264. PubMed ID: 36701047
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Clinical and genetic characteristics of chinese patients with Birt-Hogg-Dubé syndrome.
    Liu Y; Xu Z; Feng R; Zhan Y; Wang J; Li G; Li X; Zhang W; Hu X; Tian X; Xu KF; Zhang X
    Orphanet J Rare Dis; 2017 May; 12(1):104. PubMed ID: 28558743
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Unique mutation, accelerated mTOR signaling and angiogenesis in the pulmonary cysts of Birt-Hogg-Dubé syndrome.
    Nishii T; Tanabe M; Tanaka R; Matsuzawa T; Okudela K; Nozawa A; Nakatani Y; Furuya M
    Pathol Int; 2013 Jan; 63(1):45-55. PubMed ID: 23356225
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Analysis of the Birt-Hogg-Dubé (BHD) tumour suppressor gene in sporadic renal cell carcinoma and colorectal cancer.
    da Silva NF; Gentle D; Hesson LB; Morton DG; Latif F; Maher ER
    J Med Genet; 2003 Nov; 40(11):820-4. PubMed ID: 14627671
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Birt-Hogg-Dubé (BHD) syndrome: report of two novel germline mutations in the folliculin (FLCN) gene.
    Palmirotta R; Donati P; Savonarola A; Cota C; Ferroni P; Guadagni F
    Eur J Dermatol; 2008; 18(4):382-6. PubMed ID: 18573707
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 30.